Hospital de La Serena (La Serena Hospital)
La Serena, Coquimbo Region, 17000000, Chile
NCT Number: NCT01718171
Although the presence of SIRS has been described in patients with appendicitis, its progressive response related and together with progression of symptomatology from the onset of symptoms to diagnostic has not been characterized. Continuation of the systemic inflammation in patients with injury and infectious processes may result in multiple organ dysfunction and ultimately failure. As with any acute inflammatory condition, the patients' systemic inflammatory response to appendicitis will progress and become more intense with the passing of time. The purpose of this study is to characterize the systemic inflammatory response to appendicitis from the beginning of symptoms to diagnostic in patients with appendicitis submitted to emergency surgery.
Looking for future studies?
Notify Me15 year–80 year
All sexes
Observational
La Serena, Coquimbo Region, 17000000, Chile
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 0 to more than 72 hours
Four groups of time intervals divided as follows:
Group I: 0 - 24 hours Group II: 25 - 48 hours Group III: 49 - 72 hours Group IV: More than 73 hours
Time frame: from 0 to more than 72 hours
Measurements of C-reactive protein levels
Cirujanos la Serena
Other
Progression of the Systemic Inflammatory Response in Patients With Appendicitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05002829
Appendicitis, Cecal Diseases
Denver, Colorado, United States
View Trial DetailsNCT05887414
Appendicitis, Cecal Diseases
Baldwin Park, California, United States
View Trial DetailsNCT05209061
Appendicitis, Cecal Diseases
Copenhagen, Denmark
View Trial DetailsNCT04986397
Appendicitis, Cecal Diseases
Boston, Massachusetts, United States
View Trial Details